Laurel A. Beer

FDA investigator

Appears on 14 documents from 2021 to 2026, most often at sites in North Carolina. Most often cites responsibilities of quality control unit (21 CFR 211.22).

14
Documents on file
3.2
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 52 observations

Activity by year

2021: 2, 2022: 2, 2023: 4, 2024: 4, 2026: 2

Where

North Carolina 3 · New Jersey 2 · Illinois 1 · Japan 1 · Massachusetts 1 · New Hampshire 1

Is Laurel A. Beer coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 Lonza Biologics, Inc.Apr 16, 2026 · Portsmouth, New Hampshire
483 Corixa CorporationMar 12, 2026
483 Greer Laboratories, Inc.Dec 18, 2024 · Lenoir, North Carolina
483 Novartis Pharmaceuticals CorporationAug 8, 2024 · Morris Plains, New Jersey
483 Afton Scientific, LLCMay 8, 2024 · Charlottesville, Virginia
483 Patheon Manufacturing Services LLCFeb 23, 2024 · Greenville, North Carolina
483 Janssen Pharmaceuticals Inc.Dec 14, 2023 · Raritan, New Jersey

About this profile

What does Laurel A. Beer inspect?

Laurel A. Beer appears on 14 documents on file covering 14 sites, most often in North Carolina.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.160 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Laurel A. Beer is dated Apr 16, 2026.

FDA Investigator Laurel A. Beer: 483s & Inspections · FDA Intel